--- a
+++ b/clusters/9knumclustersv2/clust_110.txt
@@ -0,0 +1,14 @@
+Alanine aminotransferase (ALT) and aspartate transaminase (AST) =< . x ULN; for patients with hepatic metastases, ALT and AST =< . x ULN are acceptable\r\n* Note: if a patient experiences elevated ALT >  x ULN and elevated total bilirubin >  x ULN, clinical and laboratory monitoring should be initiated by the investigator; for patients entering the study with ALT >  x ULN, monitoring should be triggered at ALT >  x baseline
+ALT ? x ULN
+Prior ALT-
+Subjects with ALT >  x ULN at day  are not eligible for enrollment
+ALT =<  x ULN (. x ULN if considered to be due to leukemic involvement)
+ALT < . x ULN
+ALT >  x ULN
+ALT (GPT) ?  IU/L
+ALT<x ULN
+ALT ? x ULN of normal for age.
+Patients with ALT > x ULN at screening.
+Prior ALT-
+ALT > . x ULN
+ALT ? . x ULN